These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11858527)

  • 21. Application of guar gum biopolymer in the prescription of tablets with sodium ibuprofen--quality tests and pharmaceutical availability in vitro.
    Berner-Strzelczyk A; Kołodziejska J; Zgoda MM
    Polim Med; 2006; 36(4):3-11. PubMed ID: 17402228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies.
    Coviello T; Alhaique F; Dorigo A; Matricardi P; Grassi M
    Eur J Pharm Biopharm; 2007 May; 66(2):200-9. PubMed ID: 17156985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro studies on guar gum based formulation for the colon targeted delivery of Sennosides.
    Momin M; Pundarikakshudu K
    J Pharm Pharm Sci; 2004 Sep; 7(3):325-31. PubMed ID: 15576012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride.
    Rajesh KS; Venkataraju MP; Gowda DV
    Pak J Pharm Sci; 2009 Apr; 22(2):211-9. PubMed ID: 19339235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary investigation on the development of diltiazem resin complex loaded carboxymethyl xanthan beads.
    Ray S; Maiti S; Sa B
    AAPS PharmSciTech; 2008; 9(1):295-301. PubMed ID: 18446495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices.
    Asare-Addo K; Conway BR; Larhrib H; Levina M; Rajabi-Siahboomi AR; Tetteh J; Boateng J; Nokhodchi A
    Colloids Surf B Biointerfaces; 2013 Nov; 111():384-91. PubMed ID: 23850747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guar-based monolithic matrix systems: effect of ionizable and non-ionizable substances and excipients on gel dynamics and release kinetics.
    Dürig T; Fassihi R
    J Control Release; 2002 Apr; 80(1-3):45-56. PubMed ID: 11943386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A three-layer guar gum matrix tablet for oral controlled delivery of highly soluble metoprolol tartrate.
    Krishnaiah YS; Karthikeyan RS; Satyanarayana V
    Int J Pharm; 2002 Jul; 241(2):353-66. PubMed ID: 12100863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets.
    Kaialy W; Bello H; Asare-Addo K; Nokhodchi A
    J Pharm Pharmacol; 2016 Nov; 68(11):1396-1402. PubMed ID: 27714817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of active pharmaceutical material release from a novel 'tablet in capsule system' containing an effervescent blend.
    Gohel MC; Sumitra G M
    J Control Release; 2002 Feb; 79(1-3):157-64. PubMed ID: 11853927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of oral controlled-release tablet formulations based on diltiazem-carrageenan complex.
    Bonferoni MC; Rossi S; Ferrari F; Caramella C
    Pharm Dev Technol; 2004; 9(2):155-62. PubMed ID: 15202574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of similarity factor in development of controlled-release diltiazem tablet.
    Peh KK; Wong CF
    Drug Dev Ind Pharm; 2000 Jul; 26(7):723-30. PubMed ID: 10872090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation development and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M.
    Qazi F; Shoaib MH; Yousuf RI; Qazi TM; Mehmood ZA; Hasan SM
    Pak J Pharm Sci; 2013 Jul; 26(4):653-63. PubMed ID: 23811439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-layer guar gum matrix tablet formulations for oral controlled delivery of highly soluble trimetazidine dihydrochloride.
    Krishnaiah YS; Karthikeyan RS; Gouri Sankar V; Satyanarayana V
    J Control Release; 2002 May; 81(1-2):45-56. PubMed ID: 11992677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride.
    Gambhire MN; Ambade KW; Kurmi SD; Kadam VJ; Jadhav KR
    AAPS PharmSciTech; 2007 Sep; 8(3):E73. PubMed ID: 17915823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: optimization of bioadhesion, dissolution, and diffusion parameters.
    Singh B; Ahuja N
    Drug Dev Ind Pharm; 2002 Apr; 28(4):431-42. PubMed ID: 12056536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
    Vostalová L; Rabisková M; Medvecká G
    Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purified guar galactomannan as an improved pharmaceutical excipient.
    Gebert MS; Friend DR
    Pharm Dev Technol; 1998 Aug; 3(3):315-23. PubMed ID: 9742552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of guar gum from different sources for the preparation of prolonged-release or colon-specific dosage forms.
    Acartürk F; Celkan A
    Pharm Dev Technol; 2009; 14(3):271-7. PubMed ID: 19519181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.